What's new around emerging, innovative materials and nanomaterials?

Save-the-Date: Future-proof Approaches for Risk Governance – Lessons Learned from Nanomaterials

29. September 2022

Organised by the NMBP-13 projects NANORIGO, RiskGONE and Gov4Nanoc in collaboration with the OECD’s Working Party on Manufactured Nanomaterials (WPMN). We invite you to register your interest in participating in our conference to help shape international approaches to addressing future challenges in risk governance of nano- & advanced materials. This includes safe- and sustainable by […]

Read more

NanoBioQuant invites you to its Final Conference

7. September 2022

New approaches for risk assessment and detection of nanoparticles in peripheral tissues The assessment of the safety of nanomaterials (NM) and nanotechnology products is based on toxicological studies that need to be in accordance with regulatory criteria. In this context, the distribution of NM in the organism plays a key role in understanding NM effects. […]

Read more

InnoMat.Life final conference

11. May 2022

From Nano- to Advanced Materials: Lessons learnt in InnoMat.Life 27. – 28.06.2022, Berlin, Germany This conference addresses stakeholders from policy, science, industry and NGOs who are dealing with regulatory implications of innovative materials in the context of chemical safety. InnoMat.Life will present the final project outcomes and aims to discuss them in a broader context of other […]

Read more

Save the date: Particle Based Materials Symposium 2022 – Enhancing Sustainability 6.-7.10.22

2. May 2022

Scope The goal of the Particle Based Materials Symposium is to bring together scientists and engineers from different communities that all share the goal of creating functionality in materials using particles. The synthesis, processing and materials integration of particles into thin films, bulk matrices, fibers or other geometries are covered by this symposium. Focus Particles and […]

Read more

FDA Publishes Final Guidance for Industry on Nanomaterials in Drug Products

28. April 2022

The U.S. Food and Drug Administration (FDA) has published the final guidance document for industry “Drug Products, Including Biological Products, that Contain Nanomaterials” . FDA states that the guidance applies broad array of FDA-regulated products such as human drug products, including those that are biological products, in which a nanomaterial is present in the finished […]

Read more
Skip to content